|
|
#1
08-31-2016, 03:50 PM
|
|||
|
|||
**vartis bid to sell new biosimilar crimped by U.S. court battles
ZURICH (Reuters) - **vartis has won U.S. approval for a copy of Amgen's blockbuster arthritis drug Enbrel, but the Swiss drugmaker's bid to muscle in on the medicine's $4.7 billion in annual U.S. revenue remains blocked by court battles. ??????? ??????: **vartis bid to sell new biosimilar crimped by U.S. court battles || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
